Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action

NCT01638715 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT01638715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01638715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action
Lead sponsor
Medical University of Vienna
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2012
Completion date
August 1, 2018
Enrollment
115 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis